CAVAGNA, LORENZO
 Distribuzione geografica
Continente #
NA - Nord America 3.239
EU - Europa 2.054
AS - Asia 1.308
AF - Africa 8
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 6.622
Nazione #
US - Stati Uniti d'America 3.209
CN - Cina 1.137
IE - Irlanda 906
FI - Finlandia 278
DE - Germania 213
UA - Ucraina 205
IT - Italia 197
SG - Singapore 103
SE - Svezia 76
AT - Austria 64
GB - Regno Unito 42
IN - India 31
CA - Canada 29
FR - Francia 29
BE - Belgio 19
JP - Giappone 11
CZ - Repubblica Ceca 6
PT - Portogallo 6
HK - Hong Kong 5
TR - Turchia 5
AU - Australia 4
IL - Israele 4
MK - Macedonia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
EC - Ecuador 3
NL - Olanda 3
AM - Armenia 2
DK - Danimarca 2
DZ - Algeria 2
MU - Mauritius 2
NG - Nigeria 2
PH - Filippine 2
RU - Federazione Russa 2
AZ - Azerbaigian 1
BO - Bolivia 1
BR - Brasile 1
CY - Cipro 1
ES - Italia 1
EU - Europa 1
IQ - Iraq 1
KG - Kirghizistan 1
MA - Marocco 1
MX - Messico 1
MY - Malesia 1
OM - Oman 1
RO - Romania 1
SA - Arabia Saudita 1
SC - Seychelles 1
VN - Vietnam 1
Totale 6.622
Città #
Dublin 891
Chandler 770
Jacksonville 324
Nanjing 286
Ashburn 245
Boardman 233
Princeton 160
Helsinki 148
Lawrence 140
Wilmington 125
Beijing 117
Nanchang 115
Medford 104
Shanghai 94
Shenyang 87
Hebei 80
Changsha 77
Jiaxing 77
Singapore 66
Tianjin 65
Ann Arbor 55
New York 55
Vienna 54
Pavia 52
Hangzhou 49
Milan 43
Woodbridge 31
Los Angeles 30
Norwalk 27
Pune 23
Seattle 22
Fairfield 20
Toronto 19
Brussels 18
Washington 17
Chicago 16
Redwood City 11
Verona 11
Houston 10
San Francisco 10
Tokyo 10
Munich 8
Dallas 7
Jinan 7
Auburn Hills 6
Brno 6
Guangzhou 6
Ningbo 6
London 5
Nuremberg 5
Ottawa 5
Piscataway 5
Berlin 4
Borås 4
Chaozhou 4
Dearborn 4
Lanzhou 4
Redmond 4
Tel Aviv 4
Zhengzhou 4
Changchun 3
Chengdu 3
Des Moines 3
Esslingen am Neckar 3
Fagnano Olona 3
Falls Church 3
Frankfurt am Main 3
Lisbon 3
Moncalieri 3
Napoli 3
Orange 3
Quito 3
San Giuliano Milanese 3
Settimo Torinese 3
Abuja 2
Amadora 2
Aosta 2
Brescia 2
Bulgorello 2
Canberra 2
Canyon Country 2
Castelbuono 2
Collegno 2
Conegliano 2
Cupertino 2
Davis 2
Fremont 2
Fuzhou 2
Genova 2
Gunzenhausen 2
Haikou 2
Hyderabad 2
Kunming 2
Lodi 2
Rome 2
Shenzhen 2
Tizi Ouzou 2
Turin 2
Vanzago 2
Yerevan 2
Totale 4.979
Nome #
Prognostic value of antisynthetase antibodies in patients affected by polymiositis/dermatomyositis with interstitial lung disease 91
Interessamento cutaneo nella dermatomiosite 85
Association between anti-dsDNA titre increase and thymoma relapse 80
A hyper-ferritinemia syndrome evolving in recurrent macrophage activation syndrome, as an onset of amyopathic juvenile dermatomyositis: a challenging clinical case in light of the current diagnostic criteria. 78
Spondiliti e spondilodisciti batteriche. 74
2-DE and LC-MS/MS for a Comparative Proteomic Analysis of BALf from Subjects with Different Subsets of Inflammatory Myopathies 74
Anti-neutrophil cytoplasmic antibodies (ANCA) ( Review ) [Anticorpi anticitoplasma dei neutrofili (ANCA)] 72
Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis. 71
Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases 68
Frequency of Th1, Th2 and Th17 producing T lymphocytes in bronchoalveolar lavage of patients with systemic sclerosis. 67
Spinal hemorrhage in eosinophilic granulomatosis with polyangiitis (Churg-Strauss) 67
Anticyclic citrullinated peptide antibodies as markers of erosive arthritis in antisynthetase syndrome. 66
Inflammatory myopathy in a patient with cutaneous findings of pityriasis rubra pilaris: a case of wong's dermatomyositis 66
Early electroretinografic changes in elderly RA patients treated with hydroxychloroquine 63
Autoantibodies to heterogeneous nuclear ribonucleoproteins. 63
Overuse of prescription and otc non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis and osteoarthritis. 62
Timing of onset affects arthritis presentation pattern in antisynthetase syndrome 62
Anti-Ma2/Ta antibodies in a woman with primary lateral sclerosis-like phenotype and Sjogren syndrome 62
A case of adult onset Still's disease treated with infliximab - Reply 62
La poliangioite microscopica. 60
Nailfold capillaroscopy characteristics of antisynthetase syndrome and possible clinical associations: Results of a multicenter international study 59
Is it really infective endocarditis? Distinguishing systemic vasculitis from its mimics 59
Effects of anti-TNF alpha drugs on disability in patients with rheumatoid arthritis: Long-term real-life data from the Lorhen registry 58
Combined interventional sialendoscopy and intraductal steroid therapy for recurrent sialadenitis in Sjögren's syndrome: Results of a pilot monocentric trial 58
Rheumatoid arthritis and renal light-chain deposition disease: long-term effectiveness of TNF-alpha blockade with etanercept 57
Pain in arthritis 57
Predictors of response to anti-TNF therapy in RA patients with moderate or high DAS28 scores. 57
Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis. 57
Therapeutic options in Anti-Jo1 antisynthetase syndrome with interstitial lung disease. 57
Compressive cervical myelopathy due to massive periodontoid calcium pyrophosphate crystal deposition 55
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study. 55
Biosimilars: Lights and shadows in rheumatology 55
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 55
Performance of classification criteria for gout in early and established disease 55
"Emergency" Cochlear Implantation in Labyrinthitis Ossificans Secondary to Polyarteritis Nodosa: How to Face a Rare Entity 55
Serologic Profile and Mortality Rates of Scleroderma Renal Crisis in Italy 54
Cardiovascular involvement in rheumatoid arthritis [L'interessamento cardiaco nell'artrite reumatoide] 54
Clinical features of ANCA-positive systemic lupus erythematosus: report of two cases. 54
Diagnostic Arthrocentesis for Suspicion of Gout Is Safe and Well Tolerated 54
Pain and rheumatology: An overview of the problem 53
Undiagnosed connective tissue diseases High prevalence in pulmonary arterial hypertension patients 53
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 53
Anti-Ro52 antibodies positivity in antisynthetase syndrome: a single centre cohort study 53
Pulmonary arterial hypertension in antisynthetase syndrome: comment on the article by Chatterjee and Farver. 52
Therapy of necrotizing arteritis | [La terapia delle vasculiti necrotizzanti] 52
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 52
Biotechnological drugs: The breakthrough in autoimmune rheumatic conditions 52
Clinical and electrophysiological evaluation of peripheral neuropathy in rheumatoid arthritis. 51
Study for updated gout classification criteria: Identification of features to classify gout 51
Atherosclerosis and rheumatoid arthritis: more than a simple association 50
Clinical spectrum time course of interstitial pneumonia with autoimmune features in patients positive for antisynthetase antibodies 50
Clinical spectrum time course in anti jo-1 positive antisynthetase syndrome: Results from an international retrospective multicenter study 50
Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome 50
Prescribing pattern of drugs in the treatment of osteoarthritis in Italian general practice: The effect of rofecoxib withdrawal 49
Chromosomally integrated human herpesvirus 6 in a patient with systemic lupus erythematosus. 49
Modulating the co-stimulatory signal for T cell activation in rheumatoid arthritis: Could it be the first step of the treatment? 49
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy 49
Brief Report: Validation of a Definition of Flare in Patients With Established Gout 48
Comparison of brain natriuretic peptide (BNP) and NT-proBNP in screening for pulmonary arterial hypertension in patients with systemic sclerosis. 48
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine 48
Clinical spectrum of anti-Jo-1-associated disease 48
Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases 47
The burden of nephrotoxic drug prescriptions in patients with chronic kidney disease: A Retrospective population-based study in Southern Italy 47
One year in review 2019: idiopathic inflammatory myopathies 47
New perspectives in the classification and treatment of systemic lupus erythematosus: the central role of kidney involvement] [Nuovi aspetti classificativi e terapeutici del lupus eritematoso sistemico: centralità dell'interessamento renale] 46
Early morpho-functional changes in patients treated with hydroxychloroquine: a prospective cohort study 46
Telemedicine: a useful tool but not the holy grail. Response to: 'Telemedicine will not keep us apart in the COVID-19 pandemic' by Perniola et al 46
Cobalt hip prosthesis intoxication mimicking an autoimmune disease 46
Cobalt hip prosthesis intoxication mimicking an autoimmune disease 45
CT-guided biopsy in the differential diagnosis of Sjogren syndrome associated cystic lung disease: A case of lung nodular AL-k amyloidosis 45
Long-term safety of abatacept in patients with rheumatoid arthritis 44
New criteria needed for antisynthetase syndrome 44
Rheumatoid arthritis in beta-thalassemic trait: clinical, serologic and immunogenetic profile. 44
Idiopathic inflammatory myopathies: Narrative review of unmet needs in clinical practice guidelines 44
Second Wave Antibodies in Autoimmune Renal Diseases: The Case of Lupus Nephritis 44
Clinical and electrophysiological evaluation of peripheral neuropathy in rheumatoid arthritis 43
Successful treatment with baricitinib in a patient with refractory cutaneous dermatomyositis 43
Patients with interstitial lung disease secondary to autoimmune diseases: How to recognize them? 43
Severe muscle damage with myofiber necrosis and macrophage infiltrates characterize anti-Mi2 positive dermatomyositis 43
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 43
Miositi idiopatiche dell’adulto: analisi retrospettiva di 45 casi. 42
Sinonasal Surgery in Wegener's Granulomatosis: Is It Time to Go On? 42
Genetics and novel aspects of therapies in systemic lupus erythematosus 42
Infliximab in the treatment of adult Still's disease refractory to conventional therapy 42
Multidisciplinary Approach in the Early Detection of Undiagnosed Connective Tissue Diseases in Patients With Interstitial Lung Disease: A Retrospective Cohort Study 42
The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseases 41
Thrombocytopenia in idiopathic inflammatory myopathies: a case series analysis 41
Erratum: Spinal hemorrhage in eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (Journal of Neurology (2014) 261 (438-440) DOI: 10.1007/s00415-013-7217-3) 41
Colony-stimulating factor-1: A potential biomarker for lupus nephritis 39
Pulmonary nocardiosis in a patient affected by anti-MDA5-positive amyopathic dermatomyositis under immunosuppressive therapy 39
Celiac Disease Prevalence is Increased in Primary Sjögren's Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study 39
Polyarthrite rhumatoïde associée à un trait bêta-thalassémique : aspect clinique, sérologique et immunogénétique 38
Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis 38
One year in review 2018: idiopathic inflammatory myopathies 38
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course 37
Capillary leak syndrome in a patient with cancer-associated anti-transcriptional intermediary factor 1γ dermatomyositis treated with rituximab 36
Evaluation of EBV- and HCMV-Specific T Cell Responses in Systemic Lupus Erythematosus (SLE) Patients Using a Normalized Enzyme-Linked Immunospot (ELISPOT) Assay 36
Idiopathic inflammatory myopathies: one year in review 2021 36
Neutrophil Extracellular Traps in the Autoimmunity Context 35
Combined ultrasound–CT approach to monitor acute exacerbation of interstitial lung disease 35
Totale 5.197
Categoria #
all - tutte 34.976
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.976


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020343 0 0 0 39 3 44 17 60 13 99 65 3
2020/2021512 45 35 17 46 14 55 2 92 52 66 68 20
2021/2022745 36 23 30 6 17 14 22 45 35 9 105 403
2022/20232.427 270 193 32 194 195 194 6 149 1.076 10 56 52
2023/20241.062 110 196 38 61 67 269 38 61 7 78 37 100
2024/2025436 75 209 128 24 0 0 0 0 0 0 0 0
Totale 7.041